Ginkgolide C (GGC), isolated from Ginkbiloba, has been reported to display various pharmacological actions, although, anti-
cancer effect of GGC has been poorly understood till now. This study aimed to investigate whether GGC can exhibit anti-neoplastic effects against
colon cancer cells and explore underlying mechanism. The Wnt/β-
catenin signaling can regulate cell proliferation, survival,
metastasis, and migration. Wnt/β-
catenin signaling pathway plays important role in
colorectal cancer (CRC) and acts as a potential therapeutic target. Abnormal activation of this signaling cascades has been reported in colon CRC. We found that GGC down-regulated Wnt/β-
catenin signaling cascade. GGC inhibited the expression of Wnt3a, β-
catenin, and β-
catenin down-stream signals (Axin-1, p-GSK3β, and β-TrCP). Also, GGC suppressed the expression of Wnt/β-
catenin pathway target genes including c-myc,
cyclin D1, and
survivin. Additionally, GGC induced apoptosis and suppressed cell proliferation, invasion, and migration. GGC down-regulated the expressions of
matrix metalloproteinase (MMP)-9 and MMP-2
proteins. Moreover, silencing of β-
catenin by
small interfering RNA (
siRNA) enhanced the GGC-induced apoptosis and inhibitory action of GGC on invasion. Overall, our results indicate that GGC can reduce proliferation and promote apoptosis in
colon cancer cells through inhibition of the Wnt/β-
catenin signaling pathway. Thus, GGC can serve as a potent therapeutic agent for management of
colon cancer as a novel wnt signaling inhibitor.